NMRA - Neumora Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NMRA is currently covered by 5 analysts with an average price target of $12.42. This is a potential upside of $11.64 (1492.31%) from yesterday's end of day stock price of $0.78.

Neumora Therapeutics's activity chart (see below) currently has 0 price targets and 21 ratings on display. The stock rating distribution of NMRA is 95.24% BUY and 4.76% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 10% with an average time for these price targets to be met of 24.4 days.

Highest price target for NMRA is $29, Lowest price target is $7, average price target is $17.

Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 14-Feb-2025. First documented stock forecast 10-Oct-2023.

Best performing analysts who are covering NMRA - Neumora Therapeutics:

Ami Fadia Douglas Tsao Brian Abrahams Tessa Romero Geoff Meacham

Currently out of the existing stock ratings of NMRA, 20 are a BUY (95.24%), 1 are a HOLD (4.76%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

4 months 4 days ago
(14-Feb-2025)

0/3 (0%)

$19.13 (175.99%)

Buy

$7

$5.98 (586.27%)

$18

5 months 12 days ago
(06-Jan-2025)

1/2 (50%)

$4.52 (182.26%)

122

Buy

$23

5 months 16 days ago
(02-Jan-2025)

0/5 (0%)

$12.22 (113.36%)

Buy

$29

$27.98 (2743.14%)

$29

6 months 27 days ago
(22-Nov-2024)

0/4 (0%)

$19.26 (197.74%)

Hold

$15

$13.98 (1370.59%)

$22

7 months 13 days ago
(05-Nov-2024)

0/4 (0%)

$3.09 (25.94%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NMRA (Neumora Therapeutics) average time for price targets to be met?

On average it took 24.4 days on average for the stock forecasts to be realized with a an average price target met ratio 10

Which analyst has the current highest performing score on NMRA (Neumora Therapeutics) with a proven track record?

AMI FADIA

Which analyst has the current lower performing score on NMRA (Neumora Therapeutics) with a proven track record?

GEOFF MEACHAM

Which analyst has the most public recommendations on NMRA (Neumora Therapeutics)?

Ami Fadia works at NEEDHAM and has 7 price targets and 8 ratings on NMRA

Which analyst is the currently most bullish on NMRA (Neumora Therapeutics)?

Brian Abrahams with highest potential upside - $27.98

Which analyst is the currently most reserved on NMRA (Neumora Therapeutics)?

Ami Fadia with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?